CGEM
Price:
$12.54
Market Cap:
$730.17M
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
NASDAQ
Ticker
CGEM
According to Cullinan Oncology, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Cullinan Oncology, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CGEM's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Cullinan Oncology, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
The current Dividend Yield of Cullinan Oncology, Inc. (CGEM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Cullinan Oncology, Inc.’s Dividend Yield is less than Bolt Biotherapeutics, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Autolus Therapeutics plc (0%), less than Sana Biotechnology, Inc. (0%), less than Olema Pharmaceuticals, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Zentalis Pharmaceuticals, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Talaris Therapeutics, Inc. (0%), less than Adicet Bio, Inc. (0%), less than Vor Biopharma Inc. (0%), less than Lyell Immunopharma, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Revolution Medicines, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $22.14M | |
0% | $1.38B | |
0% | $12.37M | |
0% | $782.39M | |
0% | $582.73M | |
0% | $503.07M | |
0% | $131.12M | |
0% | $230.19M | |
0% | $102.89M | |
0% | $3.05B | |
0% | $300.00M | |
0% | $621.09M | |
0% | $116.44M | |
0% | $74.16M | |
0% | $54.25M | |
0% | $265.26M | |
0% | $521.60M | |
0% | $181.50M | |
0% | $9.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cullinan Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cullinan Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Cullinan Oncology, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Cullinan Oncology, Inc. (CGEM)?
What is the highest Dividend Yield for Cullinan Oncology, Inc. (CGEM)?
What is the 3-year average Dividend Yield for Cullinan Oncology, Inc. (CGEM)?
What is the 5-year average Dividend Yield for Cullinan Oncology, Inc. (CGEM)?
How does the current Dividend Yield for Cullinan Oncology, Inc. (CGEM) compare to its historical average?